What sunscreen ingredient did the FDA approve?

FDA approves bemotrizinol, the first new U.S. sunscreen ingredient in decades

The U.S. Food and Drug Administration has approved bemotrizinol (also called BEMT), described as the first new sunscreen ingredient for the U.S. market in roughly 25–30 years.

Bemotrizinol is already used in other parts of the world—coverage in the news roundup indicates it is familiar in Europe and Asia—and the FDA decision expands the set of active ingredients Americans can choose from when buying sunscreen.

Why the approval matters

Sunscreen filters are central to reducing skin damage from ultraviolet (UV) radiation, including harm associated with long-term sun exposure. A new FDA-approved ingredient can increase options for consumers and may support product innovation for brands trying to balance effectiveness, tolerability, and formulation performance.

The FDA action is particularly notable because it comes after years in which U.S. sunscreen ingredients were not meaningfully expanded. Having a newer active ingredient can also matter for people who look for alternatives due to personal preferences about how products feel on the skin.

What’s still unclear

The provided stories focus on the regulatory milestone; they do not spell out detailed performance comparisons versus older U.S. ingredients, such as specific real-world effectiveness or skin-comfort tradeoffs. Consumers should still follow standard guidance on proper sunscreen use (adequate coverage and reapplication) regardless of which approved active ingredient a product contains.

Bottom line

FDA’s approval of bemotrizinol means Americans gained access to a sunscreen ingredient long used abroad, marking a rare update to the U.S. sunscreen ingredient list in decades.